Marshall S. Stanton, SVP, Clinical & MD Affair at ARTIVION, INC. (AORT), sold 15,000 shares at $29.50 ($443K) on 2025-06-17, disclosed to the SEC on 2025-06-18.
Scheduled sale ($442k) by SVP, Clinical & MD Affair under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.50 | 1,236 | $36K | 8.2% |
| 2 | $29.50 | 13,764 | $406K | 91.8% |
| Total | $29.50 avg | 15,000 | $443K | 100% |
| Filing → |
| AORT | SELL | 2026-02-25 | $136K | — | Filing → |
| AORT | SELL | 2025-11-24 | $1.3M | — | Filing → |
| AORT | SELL | 2025-11-24 | $4.3M | — | Filing → |